Clinical trial
The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide…
NCT00346970 · Hannover Medical School, Other · Completed
Key facts
| NCT number | NCT00346970 |
|---|---|
| Title | The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study) |
| Official title | Randomized Clinical Trial to Study the Effect of Extended Release Niacin on Endothelial Function, Oxidative Stress and Endothelial Progenitor Cells in Patients With the Metabolic Syndrome. |
| Lead sponsor | Hannover Medical School, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome |
| Intervention type | Drug |
| Interventions | Extended-Release Niacin, Placebo |
| Enrollment | 32 |
| Start date | Jul 1, 2006 |
| Completion | Jul 1, 2007 |
| First posted | Jul 4, 2006 |
| Last update posted | May 6, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: